The Oncology Institute Inc./$TOI
13:30
09:10
04:45
00:25
20:00
1D1W1MYTD1Y5YMAX
About The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.
Ticker
$TOI
Sector
Primary listing
Industry
Health Care Providers & Services
Headquarters
Employees
825
ISIN
US68236X1000
Website
TOI Metrics
BasicAdvanced
$215M
-
-$0.70
0.06
-
Price and volume
Market cap
$215M
Beta
0.06
52-week high
$3.50
52-week low
$0.60
Average daily volume
1.9M
Financial strength
Current ratio
1.794
Quick ratio
1.502
Long term debt to equity
1,884.889
Total debt to equity
2,020.063
Interest coverage (TTM)
-6.87%
Profitability
EBITDA (TTM)
-45.475
Gross margin (TTM)
14.70%
Net profit margin (TTM)
-15.96%
Operating margin (TTM)
-12.91%
Revenue per employee (TTM)
$490,000
Management effectiveness
Return on assets (TTM)
-17.66%
Return on equity (TTM)
-277.62%
Valuation
Price to revenue (TTM)
0.447
Price to book
41.75
Price to tangible book (TTM)
-13.07
Price to free cash flow (TTM)
-9.416
Free cash flow yield (TTM)
-10.62%
Free cash flow per share (TTM)
-25.28%
Growth
Revenue change (TTM)
17.64%
Earnings per share change (TTM)
-13.96%
3-year revenue growth (CAGR)
24.37%
3-year earnings per share growth (CAGR)
98.56%
TOI News
AllArticlesVideos
The Oncology Institute set to join the Russell 2000® and Russell 3000® Indexes
GlobeNewsWire·3 weeks ago
The Oncology Institute Welcomes Dr. Jeff Langsam as Chief Clinical Officer
GlobeNewsWire·1 month ago
The Oncology Institute to Participate at the B. Riley Securities 25th Annual Institutional Investor Conference
GlobeNewsWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for The Oncology Institute Inc. stock?
The Oncology Institute Inc. (TOI) has a market cap of $215M as of June 21, 2025.
What is the P/E ratio for The Oncology Institute Inc. stock?
The price to earnings (P/E) ratio for The Oncology Institute Inc. (TOI) stock is 0 as of June 21, 2025.
Does The Oncology Institute Inc. stock pay dividends?
No, The Oncology Institute Inc. (TOI) stock does not pay dividends to its shareholders as of June 21, 2025.
When is the next The Oncology Institute Inc. dividend payment date?
The Oncology Institute Inc. (TOI) stock does not pay dividends to its shareholders.
What is the beta indicator for The Oncology Institute Inc.?
The Oncology Institute Inc. (TOI) has a beta rating of 0.06. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
